IMNP - Immune Pharmaceuticals Inc. Mon 27'th Feb 2017
Stock analysis for Mon 27'th Feb 2017 (Updated daily)
Hold candidate since 2017-02-24
Immune Pharmaceuticals Inc. Stock Analysis
No changes to the price of Immune Pharmaceuticals Inc. in the last trading day. The price has been going up and down for this period, and there has been a -6.91% loss for the last 2 weeks. Volume fell in the last day by -0.50 million shares and ,in total, 2.22 million shares bought and sold for approximately USD 378 060. You should note that falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Immune Pharmaceuticals Inc. lies in the lower of a very wide and weak falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at USD 0.16 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -2.8% during the next 3 months and, with 90% probability hold a price between USD 0.16 and USD 0.26 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday February 23, 2017, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Immune Pharmaceuticals Inc. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at USD 0.18 and USD 0.19. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This doesnâ€™t cause any direct divergence but may be an early warning and a possible "turning point".
Relative Strength Index (RSI)
RSI14 is 38 and the stock is currently not being overbought or oversold
Support & Resistance
Immune Pharmaceuticals Inc. finds support from accumulated volume at USD 0.17, USD 0.17, and USD 0.17. On the upside the stock meets some resistance from accumulated volume at USD 0.19, USD 0.18 and USD 0.20.
This stock may move much during a day (volatility) and with periodic low trading volume this stockstock is considered to be "high risk". During the last day, the stock moved USD 0.01 between high and low, or 7.14%. For the last week the stock has had a daily average volatility of 9.14%.
Our recommended stoploss: USD 0.17 (-0.00%) ( based on support and risk)
Immune Pharmaceuticals Inc. holds several negative signals and isolated this should give a sell recommendiation, but due to general chance for a turnaround situation we recommend a hold or accumulate position awaiting further development.